LobbyingEsteve Pharmaceuticals lobbying by quarter
Esteve Pharmaceuticals's latest lobbying report covers Q2 2026, at $10K. Its first report covers Q1 2026; the issues it reports most are Health Issues and Medicare/Medicaid.
Esteve Pharmaceuticals
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $20K
- Last 3 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2026 | $10K | 1 |
| Q2 2026 | $10K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$10K · 2 reports
- Medicare and Medicaid$10K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Arnold & Porter Kaye Scholer | $20K | 2 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Arnold & Porter Kaye Scholer | $10K |
| 04/20for Q1 | Arnold & Porter Kaye Scholer | $10K |
| 03/23for Q1 | Arnold & Porter Kaye Scholer | Under $5,000 |